Cabaletta Bio Inc.

05/12/2022 | Press release | Distributed by Public on 05/12/2022 05:07

DesCAARTes™ trial clinical and translational data from cohorts A3 and A4 and 28-day safety data from cohort A5 expected to be presented at upcoming scientific meetings in[...]